
|Videos|March 29, 2016
Disadvantages of Novel Oral Anticoagulants Compared with Vitamin K Antagonists
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the disadvantages of novel oral anticoagulants over vitamin K antagonists.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the disadvantages of novel oral anticoagulants over vitamin K antagonists.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Reduces Time in Spent in Hospital, Admission Rates in Patients With Overweight or Obesity
2
From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements
3
Atebimetinib Signals a Potential Shift in First-Line Pancreatic Cancer Outcomes
4
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
5

























